Effects of Vildagliptin addition versus standard therapy on glycemic excursion in type2 diabetic patients after coronary intervention therapy: a 8-months, randomized, open-label, parallel-group comparison.
Phase of Trial: Phase II
Latest Information Update: 20 May 2015
At a glance
- Drugs Vildagliptin (Primary) ; Gliclazide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 20 May 2015 New trial record